Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S254060, C514S254090, C544S231000, C544S371000, C544S373000, C544S349000, C544S362000, C544S363000, C544S368000, C544S370000, C544S376000, C544S395000, C544S364000
Reexamination Certificate
active
07998963
ABSTRACT:
Compounds of formula I:or pharmaceutically acceptable salts thereof, wherein Ar is indolyl, indazolyl or dihydroindolyl, and R1, R2, R3and R4are as defined herein. Also provided are pharmaceutical compositions, methods of using the compounds in the treatment of depressive, anxiolytic and other disorders associated with inhibition of the reuptake of norepinephrine, serotonin, and dopamine, and methods of preparing the compounds.
REFERENCES:
patent: 6967201 (2005-11-01), Briner et al.
patent: 7754721 (2010-07-01), Carter et al.
patent: 2009/0264404 (2009-10-01), Yamashita et al.
patent: 1178047 (2002-02-01), None
patent: 950872 (1961-03-01), None
patent: 02094799 (2002-11-01), None
patent: 03015784 (2003-02-01), None
patent: 2004080407 (2004-09-01), None
patent: 2006002464 (2006-10-01), None
patent: 2008019971 (2008-02-01), None
patent: 2008047883 (2008-04-01), None
Takeshi, K., “Medicinal Agent,” Oct. 9, 2008, JP2008239617, 1 page Abstract.
Tatsuyoshi, T., “Medicine,” May 22, 2008, JP2008115172, 1 page Abstract.
Fray, M.J., et. al “Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors,” Boporganic & Medicinal Chemistry Letters (2006) vol. 16, pp. 4349-4353.
Dorsey J. M., et. al. “Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profile,” Bioorganic & Medicinal Chemistry (2004) vol. 12, pp. 1483-1491.
Nickolson, V.J., et. al. “Presynaptic alpha-block and inhibition of noradrenaline and 5-hydrocytryptamine reuptake by a series of compounds related to mianserin,” Journal of Pharmacy Pharmacology (1981) vol. 33, pp. 760-766.
Carter David Scott
Lucas Matthew C.
Schoenfeld Ryan Craig
Weikert Robert James
Bernhardt Emily
Hall Robert C.
Roche Palo Alto LLC
LandOfFree
Arylpiperazine derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylpiperazine derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylpiperazine derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2782602